Get the Stockscreener App
1.0516
2.23%
-0.0633
Adagio Medical Holdings Inc stock is traded at $1.0516, with a volume of 2,407.
It is down -2.23% in the last 24 hours and down -16.94% over the past month.
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.
See More
Previous Close:
$1.1149
Open:
$1.09
24h Volume:
2,407
Relative Volume:
0.01
Market Cap:
$15.84M
Revenue:
-
Net Income/Loss:
$-2.54M
P/E Ratio:
-3.8948
EPS:
-0.27
Net Cash Flow:
$-1.03M
1W Performance:
-6.79%
1M Performance:
-16.94%
6M Performance:
-74.77%
1Y Performance:
+0.00%
1-Day Range:
$1.0516
$1.11
1-Week Range:
$0.97
$1.1575
52-Week Range:
$0.75
$6.78
Adagio Medical Holdings Inc Stock (ADGM) Company Profile
Name
Adagio Medical Holdings Inc
Sector
Industry
Phone
212-284-2300
Address
26051 MERIT CIRCLE, LAGUNA HILLS
Compare ADGM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADGM
Adagio Medical Holdings Inc
|
1.0516 | 15.84M | 0 | -2.54M | -1.03M | -0.27 |
|
ABT
Abbott Laboratories
|
125.56 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.62 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
364.33 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.16 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.80 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Adagio Medical Holdings Inc Stock (ADGM) Latest News
Autonomix Medical (NASDAQ:AMIX) versus Adagio Medical (NASDAQ:ADGM) Head-To-Head Review - Defense World
Midday Stock Roundup: Pro-Dex Up 9.9% During Trading - Orange County Business Journal
Adagio Medical cuts workforce and pauses cryo catheter launch in EU - Yahoo Finance
Adagio Medical Restructures to Focus on FDA Approval - TipRanks
Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation - Marketscreener.com
Pre-market Movers: ISPC, TH, IVVD, TOVX... - RTTNews
Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference - Marketscreener.com
Adagio Medical Holdings ends agreement with Fjord Ventures By Investing.com - Investing.com South Africa
Adagio Medical Holdings ends agreement with Fjord Ventures - MSN
Adagio Medical Holdings Says On January 30, Terminated Facilities And Services Agreement With Fjord Ventures - Marketscreener.com
Adagio Medical Holdings addresses financial discrepancies, plans Nasdaq compliance - Investing.com
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Pre-market Movers: PHIO, IKT, CDT, WHLM... - RTTNews
Lulu’s Fashion Lounge Holdings, Inc. (NASDAQ: LVLU) Enters into Third Amendment to Credit AgreementOn December 13, 2024, Lulu’s Fashion Lounge Holdings, Inc. (referred to as “Lulus” or the “Company”) announced that its wholly-owned subsidiaries ha - Defense World
Adagio Medical Holdings Announces CEO Transition and New Appointment - Defense World
Adagio Medical announces Todd Usen as new CEO and director - Yahoo Finance
Adagio Medical names Todd Usen as CEO & director - Medical Buyer
Adagio Medical Appoints Todd Usen as Chief Executive Officer and Director - citybiz
Adagio Medical appoints new CEO and board chair - Investing.com
Adagio Medical Appoints Industry Veteran Todd Usen as CEO in Strategic Leadership Overhaul - StockTitan
Adagio Medical To List on Nasdaq Through Business Combination wi - GuruFocus.com
Field Medical wins FDA breakthrough designation - BioWorld Online
ADGM stock touches 52-week low at $2.2 amid market shifts - Investing.com Australia
ADGM stock touches 52-week low at $2.2 amid market shifts By Investing.com - Investing.com South Africa
Initial Procedures Completed in Ventricular Tachycardia Cryoablation System Trial - MPO-mag
Adagio Medical Holdings Reports Third Quarter 2024 Earnings - Yahoo Finance
Adagio Medical revenue up 351% in Q3 2024 - Medical Buyer
Adagio Medical Holdings Inc (ADGM) Quarterly 10-Q Report - Quartzy
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Adagio Medical Reports 351% Revenue Surge, Secures CMS Coverage for Cryoablation Device | ADGM Stock News - StockTitan
Perceptive Advisors LLC Acquires Significant Stake in Adagio Med - GuruFocus.com
ADGM Stock Hits 52-Week Low at $2.4 Amid Market Challenges - Investing.com
Tenor Capital Management's Strategic Acquisition of Aeries Techn - GuruFocus.com
Adagio Medical to Present at the Stifel 2024 Healthcare Conference - Marketscreener.com
Adagio Medical's VT Cryoablation System begins pivotal FDA study - Investing.com India
Adagio Medical's VT Cryoablation System begins pivotal FDA study By Investing.com - Investing.com UK
FDA OKs study of Medtronic’s Affera in ventricular tachycardia - BioWorld Online
Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias - The Bakersfield Californian
ADGM stock touches 52-week low at $2.41 amid market challenges By Investing.com - Investing.com South Africa
ADGM stock touches 52-week low at $2.41 amid market challenges - Investing.com
ADGM stock touches 52-week low at $3.51 amid market challenges - Investing.com Australia
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Adagio Medical Holdings (NASDAQ:ADGM) Stock Quotes, Forecast and News Summary - Benzinga
ADGMAdagio Medical Holdings, Inc Latest Stock News & Market Updates - StockTitan
Adagio and ARYA IV combine to form new company focused on cardiac arrhythmia therapies - Cardiac Rhythm News
Adagio Medical goes public in SPAC merger - Mass Device
Reed Smith advises Adagio Medical on closing of business combination with ARYA Sciences Acquisition Corp IV - Reed Smith LLP
Adagio Medical Holdings Inc Stock (ADGM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.70%
1.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):